NMRD — Nemaura Medical Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $19.51m
- $0.08m
Brief: Nemaura Medical Files Amended 10-Q For The Quarter Ended June 30, 2022
Brief: Nemaura Medical Inc- Unable To File Its QTRLY Report On Form 10-Q For The Quarter Ended Dec 31, 2022 By The Original Due Date For Such Filing
Nemaura Medical Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: Nemaura Medical Announces Pricing Of Approximately $8.4 Million Registered Direct Offering And Concurrent Private Placement
Nemaura up on purchase order for wearable glucose monitor from HealthFleet
Brief: Nemaura Medical Receives First Purchase Order From U.S. Health Provider Healthfleet
Brief: Nemaura Medical Reports Initial Patient Data From Uk Nhs Miboko Study That Demonstrates Weight Loss In 100% Of Participants
Nemaura up on starting patient studies in health program with UK's NHS
Brief: Nemaura Commences Pilot Program Of Miboko With The Nhs In The United Kingdom
Brief: Nemaura Medical Reports Fiscal Q2 Results, Provides Business Update
Nemaura Medical Inc reports results for the quarter ended in September - Earnings Summary
Brief: Nemaura Medical Inc Says Cash And Cash Equivalents At Sept 30, 2022 Were About $10.1 Million
Nemaura Medical Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Nemaura And Eversana Sign Preliminary Agreement For Large-Scale Launch Of Nemaura's Diabetes Management Program In U.S.
U.S. RESEARCH ROUNDUP-First Advantage, Renovacor, Sotera Health
Nemaura Medical Inc reports results for the quarter ended in June - Earnings Summary
Brief: Nemaura Medical reports Q1 2023 results
Nemaura Medical Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Nemaura Medical Says Justin Mclarney Terminated As CFO